Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis.
Madhurima ChatterjeeMarleen Ja Koel-SimmelinkInge Mw VerberkJoep KillesteinHugo VrenkenChristian EnzingerStefan RopeleFranz FazekasMicheal KhalilCharlotte E TeunissenPublished in: Multiple sclerosis journal - experimental, translational and clinical (2018)
Cerebrospinal fluid contactin-1 and contactin-2 reveal axonal dysfunction in various stages of multiple sclerosis and their inclusion to the biomarker panel may provide better insight into the extent of axonal damage/dysfunction.